InSCREENeX

Founded in 2009, Inscreenex GmbH is a German biotechnology company specializing in the development of advanced human cell-based systems for drug discovery and toxicity testing. With a strong commitment to innovation, the company provides proprietary technologies for the immortalization of primary cells, the generation of stable expressing cells, and the development of functional reporter cell systems.

Its expertise spans a diverse range of cell types, including epithelial cells, endothelial cells, and patient-derived material. Additionally, Inscreenex develops cell lines for high-throughput screening applications and possesses extensive experience with various molecular targets, such as GPCRs, ion channels, and transporters.

Beyond human cells, the company offers immortalization services for cells from other mammalian species, including non-human primates, livestock animals (e.g., cattle, pigs), and companion animals (e.g., dogs, cats).

Inscreenex is recognized for delivering high-quality, reliable, and science-driven services.

Website : www.inscreenex.de